Clinician's Roundtable

Host: Susan Dolan, RN, JD Guest: Anne Louise Peters, MD Athletes with diabetes face particular challenges. Dr. Anne L. Peters, author of the book Conquering Diabetes: A Cutting-Edge Comprehensive Program for Prevention and Treatment, has treated diabetic Olympic and other competitive athletes. Dr. Peters discusses issues and protective measures with host Dr. Susan Dolan.

Host: Maurice Pickard, MD Guest: William Gahl, MD, PhD Guest: Stephen Groft, PharmD Some patients wait years for a definitive diagnosis. Using a combination of scientific resources and medical expertise at the National Institutes of Health (NIH), the Undiagnosed Diseases Program now provides a place for physicians to refer patients when a diagnosis eludes them. In this segment, host Dr. Maurice Pickard, speaks with Dr. William Gahl, director of the Undiagnosed Diseases Program, and Stephen Groft PharmD, director of the Office of Rare Diseases at the NIH, about program logistics and resources, and the referral process for doctors.

Host: Mark Nolan Hill, MD Guest: Bert Mandelbaum, MD It's an array of sporting events, many occurring simultaneously, in sites and cities across a nation. The 2008 Summer Olympic Games in China presents an extraordinary challenge, in terms of providing health care to injured athletes and suddenly-ill spectators alike. Dr. Bert Mandelbaum, a practicing orthopedic surgeon and president of the Santa Monica Orthopedic and Sports Medicine Research Foundation in Santa Monica, Calif., served as chief medical officer (CMO) for the 1999 and 2003 Women's World Cup of Soccer. He joins host Dr. Mark Nolan Hill to discuss the challenges of providing care in this setting. For instance, how does the CMO coordinate with the various team physicians, many of whom will not possess the necessary license to practice medicine in the country where their team is playing?

Host: Mark Nolan Hill, MD Guest: Bert Mandelbaum, MD Intense competition and year-round scheduling demands are now common trademarks of adolescent sports. As a result, we see more and more sports-related injuries, including the all-too-frequent anterior cruciate ligament (ACL) injuries. Dr. Bert Mandelbaum, president of the Santa Monica Orthopedic and Sports Medicine Research Foundation in Santa Monica, Calif., and principal investigator of the ACL Prevention Project, shares details of his potentially groundbreaking program, with results published in the American Journal of Sports Medicine. When should young athletes begin this prevention regimen? Taking the mechanisms of prevention a step further, can we teach athletes to run, jump and land in ways that will lessen their risk of injury? Dr. Mark Nolan Hill hosts.

Host: Mark Nolan Hill, MD Guest: Bert Mandelbaum, MD We're making great progress in the diagnosis and treatment of anterior cruciate ligament (ACL) injuries suffered by young athletes. It's no longer the injury that ends a sports career, but an ACL tear can still quickly end a season. Taking our work a step further, how can we equip our athletes with strategies to prevent ACL injuries before they happen? Dr. Bert Mandelbaum, president of the Santa Monica Orthopedic and Sports Medicine Research Foundation in Santa Monica, California, is the principal investigator of the ACL Prevention Project, with results published in the American Journal of Sports Medicine. He shares details of this potentially groundbreaking program with host Dr. Mark Nolan Hill.

Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: John Buse, MD, PhD What went wrong with the glucose-lowering arm of the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Trials? Intensive therapy was expected to reduce cardiovascular events in Type 2 diabetics at high risk of cardiovascular disease. Instead, it appears to have led to an increase in mortality. Dr. John Buse, president of the American Diabetes Association and vice chair of the ACCORD Trials Steering Committee, details the confounding results of ACCORD and offers a few ideas to explain the unexpected outcomes. Dr. Matthew Sorrentino hosts.

Host: Leslie P. Lundt, MD Guest: Phil Harvey, PhD The treatment goals for schizophrenia have evolved from merely managing symptoms to improving our patients' real-world functionality. How can we best evaluate what patients can do versus what they actually do? Do some symptoms have a stronger association with poor functioning? Dr. Phillip Harvey, professor of psychiatry at Emory University School of Medicine, joins host Dr. Leslie Lundt to discuss current tools for assessing and treating schizophrenia.

Host: Leslie P. Lundt, MD Guest: Jeffrey Kaye, MD Patients around the world looking for the Holy Grail in staving off cognitive impairment have been using ginkgo biloba for years, to the tune of $1 billion in annual sales worldwide. How strong is the data to support this use? Dr. Jeffrey Kaye, director of the National Institute on Aging's Layton Aging and Alzheimer's Disease Center and the Oregon Center for Aging and Technology at Oregon Health and Sciences University, joins host Dr. Leslie Lundt to review key points of current research on ginkgo biloba.

Host: Leslie P. Lundt, MD Guest: John Nance, JD We all know that our healthcare system is far from perfect. But where should we begin to make repairs? Host Dr. Leslie Lundt welcomes John Nance, author of Why Hospitals Should Fly: The Ultimate Flight Plan to Patient Safety and Quality Care, to outline the major dysfunctions of the system. The first step to solving the problems is understanding what they are.

Host: Leslie P. Lundt, MD Guest: John Nance, JD In 2006, 3 babies in Indianapolis died when they received adult doses of heparin. The same mistake happened at the same hospital 5 years earlier. Recently, media attention has focused on the same thing - this time in Los Angeles with the twins of actor Dennis Quaid. Why can't we seem to learn from our mistakes? Attorney John Nance, author of Why Hospitals Should Fly: the ultimate flight plan to patient safety and quality care joins host Dr. Leslie Lundt to discuss how we may avoid similar mistakes in the future.